Home Medicine A topical ED drug made from deadly spider venom just cleared its first human trial

A topical ED drug made from deadly spider venom just cleared its first human trial

by Universalwellnesssystems

A new drug for erectile dysfunction (ED) may be developed from an unexpected source.according to new report from gizmodo, a Brazilian-based pharmaceutical company, has developed a topical ED treatment made from the venom of a Brazilian wandering spider. The new drug has already passed initial human trials and is expected to begin Phase 2 trials soon.

The Brazilian wandering spider, also known as the banana spider, is actually quite large. A bite from this spider can cause rapid heart rate, shock, convulsions, and even death. A side effect of the bite can also be an erection that lasts for hours. This is known as priapism and can cause permanent damage to the penis and is painful, but the fact that this spider bite causes priapism has long had a lot of science behind it. people have become interested.

Spiders that produce venom used in the production of ED drugsImage source: Ivan Kuzmin / Adobe

Now, researchers at Brazil’s Federal University of Minas Gerais have finally taken a closer look at how ED works and discovered a way to harness its power for the benefit of all men suffering from ED. But if you’re concerned about how an ED drug made from potentially deadly spider venom works, the first phase of human clinical trials is very promising.

The topical gel the researchers created appears to be effective with minimal amounts applied to the penis. The study showed that blood flow can be increased by increasing levels of nitric oxide, a molecule essential for erections, without reaching toxic levels in the bloodstream. There is a great deal of interest in using spider venom to create gel-like treatment options, as these topical treatments often have fewer side effects than traditional ED medications.

The spider venom ED treatment will now undergo additional trials, leading to larger trials. That phase is expected to begin later this month and will focus on trials in patients who have undergone prostatectomy, which can damage the nerves that help maintain an erection. The study will involve 72 people, all divided into three groups, to test the drug’s effectiveness compared to other options.

You may also like

Leave a Comment

The US Global Health Company is a United States based holistic wellness & lifestyle company, specializing in Financial, Emotional, & Physical Health.  

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Copyright ©️ All rights reserved. | US Global Health